Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

1. Khushalani, N.I.
2. Ott, P.A.
3. Ferris, R.L.
4. Cascone, T.
5. Schadendorf, D.
6. Le, D.T.
7. Sharma, M.R.
8. Barlesi, F.
9. Sharfman, W.
10. Luke, J.J.
11. Melero, I.
12. Lathers, D.
13. Neely, J.
14. Suryawanshi, S.
15. Sanyal, A.
16. Holloway, J.L.
17. Suryawanshi, R.
18. Ely, S.
19. Segal, N.H.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/JITC-2023-007364 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus